Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$511,775
New position
Shares Held
5,500
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#151
of 282 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Axxion S.A. holds $11,845,418 across 10 Biotechnology names. BNTX ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
60,000 | $6,397,200 | |
| 2 | ATAI |
AtaiBeckley Inc.
|
193,223 | $1,018,285 | |
| 3 | GHRS |
GH Research PLC
|
36,170 | $972,249 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,605 | $797,251 | |
| 5 | RPRX |
Royalty Pharma plc
|
13,771 | $772,139 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
830 | $517,538 | |
| 7 | BNTX |
BioNTech SE
This page
|
5,500 | $511,775 | |
| 8 | IOVA |
Iovance Biotherapeutics, Inc.
|
100,000 | $416,000 |
All Filings in BNTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $511,775 | 5,500 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||